| Literature DB >> 35085484 |
Wei Zhang1, Wenqun Zhong1, Beike Wang1, Jiegang Yang1, Jingbo Yang1, Ziyan Yu1, Zhiyuan Qin1, Alex Shi1, Wei Xu2, Cathy Zheng2, Lynn M Schuchter2, Giorgos C Karakousis3, Tara C Mitchell2, Ravi Amaravadi2, Meenhard Herlyn4, Haidong Dong5, Phyllis A Gimotty6, George Daaboul7, Xiaowei Xu8, Wei Guo9.
Abstract
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.Entities:
Keywords: CD8(+) T cells; ICAM-1; PD-L1; exosome; extracellular vesicles; immune suppression
Mesh:
Substances:
Year: 2022 PMID: 35085484 PMCID: PMC8881799 DOI: 10.1016/j.devcel.2022.01.002
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270